Bumrungrad Hospital Public Company Limited
BUGDF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $25,717,577 | $25,376,159 | $20,720,564 | $12,460,421 |
| % Growth | 1.3% | 22.5% | 66.3% | – |
| Cost of Goods Sold | $12,503,044 | $12,894,826 | $11,099,260 | $7,730,981 |
| Gross Profit | $13,214,533 | $12,481,333 | $9,621,304 | $4,729,440 |
| % Margin | 51.4% | 49.2% | 46.4% | 38% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $3,442,967 | $3,495,272 | $3,211,611 | $2,937,460 |
| SG&A Expenses | $4,171,336 | $4,180,152 | $3,797,944 | $3,295,906 |
| Sales & Mktg Exp. | $728,369 | $684,880 | $586,334 | $358,446 |
| Other Operating Expenses | -$122,139 | -$198,817 | -$186,969 | -$144,096 |
| Operating Expenses | $4,049,197 | $3,981,335 | $3,610,975 | $3,151,810 |
| Operating Income | $9,165,336 | $8,499,998 | $6,007,058 | $1,519,269 |
| % Margin | 35.6% | 33.5% | 29% | 12.2% |
| Other Income/Exp. Net | $270,711 | $137,658 | $41,898 | -$63,389 |
| Pre-Tax Income | $9,436,047 | $8,637,655 | $6,048,955 | $1,455,880 |
| Tax Expense | $1,603,990 | $1,582,524 | $1,072,193 | $215,847 |
| Net Income | $7,774,726 | $7,006,451 | $4,938,222 | $1,215,678 |
| % Margin | 30.2% | 27.6% | 23.8% | 9.8% |
| EPS | 9.78 | 8.08 | 6.21 | 1.53 |
| % Growth | 21% | 30.1% | 305.9% | – |
| EPS Diluted | 8.96 | 8.08 | 5.69 | 1.4 |
| Weighted Avg Shares Out | 794,911 | 867,135 | 794,838 | 794,586 |
| Weighted Avg Shares Out Dil | 867,415 | 867,415 | 867,415 | 867,415 |
| Supplemental Information | – | – | – | – |
| Interest Income | $279,473 | $140,948 | $45,954 | $68,784 |
| Interest Expense | $8,335 | $2,394 | $3,547 | $119,756 |
| Depreciation & Amortization | $1,077,236 | $1,096,768 | $1,116,875 | $1,179,922 |
| EBITDA | $10,521,618 | $9,736,817 | $7,169,887 | $2,767,976 |
| % Margin | 40.9% | 38.4% | 34.6% | 22.2% |